Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 "DICIPLE" Phase III Trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
AFSOS-SFRO Guidelines on Radiation-Induced Lung Injury.
Clinical lung cancer·2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study.
European journal of cancer (Oxford, England : 1990)·2025
[Severe hemoptysis in the onco-hematology patient].
Revue des maladies respiratoires·2023
[Hereditary hemorrhagic telangiectasia].
Revue des maladies respiratoires·2023
Slow-cooked naive T cells make better effectors.
The Journal of experimental medicine·2026
Coverage and appropriateness of influenza vaccination in adults ≥ 60 y: Provider contribution and adherence to Italian national recommendations.
Human vaccines & immunotherapeutics·2026
Interferome profiling in the blood links IFNα5-Mucin-1 axis to HIV-1 pathogenesis.
Journal of virology·2026
Research Progress on Mechanisms of Immune Tolerance Induced by Hepatitis B Surface Antigen in Chronic HBV Infection.
Journal of immunology research·2026
Research progress on the role of IL‑37 in gynecological and obstetrics‑related diseases (Review).
International journal of molecular medicine·2026